Gemcitabine-13C,15N2 hydrochloride structure
|
Common Name | Gemcitabine-13C,15N2 hydrochloride | ||
---|---|---|---|---|
CAS Number | 2757566-59-7 | Molecular Weight | 302.64 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C813CH12ClF2N15N2O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Gemcitabine-13C,15N2 hydrochlorideGemcitabine-13C,15N2 (hydrochloride) is the 13C and 15N labeled Gemcitabine hydrochloride[1]. Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[2][3]. |
Name | Gemcitabine-13C,15N2 hydrochloride |
---|
Description | Gemcitabine-13C,15N2 (hydrochloride) is the 13C and 15N labeled Gemcitabine hydrochloride[1]. Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[2][3]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C813CH12ClF2N15N2O4 |
---|---|
Molecular Weight | 302.64 |